[1] |
YIN Zhihai, WANG Juanqi, MENG Yiran, XU Qing, YANG Zhaozhi.
Investigation of patient characteristics associated with setup errors in intensity-modulated radiotherapy after breast-conserving surgery
[J]. China Oncology, 2021, 31(3): 198-202.
|
[2] |
TIAN Hua , HE Xiaoyong , WANG Daomeng , YANG Yongguo , MEI Xia , QIAN Bin .
Expression of adenylate kinase 4 in lung adenocarcinoma and its clinical significance
[J]. China Oncology, 2021, 31(2): 108-113.
|
[3] |
LI Zhijun, XU Binghe.
Research progress of resistance to aromatase inhibitor therapy in breast cancer
[J]. China Oncology, 2021, 31(2): 81-89.
|
[4] |
CHEN Yang , LIU Wei , LI Ruimin , WANG Qifeng , SHEN Xigang , TANG Wei .
Radiogenomics: association between BI-RADS mammographic imaging features and the 21-gene recurrence score
[J]. China Oncology, 2020, 30(7): 505-511.
|
[5] |
WANG Xiaoqin, FU Xinlei, MA Ruyue, YANG Lina, CHEN Yaping, ZHANG Liwen.
Sema3A regulates metastasis through epithelial-mesenchymal transition/matrix metalloproteinase-2 in epithelial ovarian cancer
[J]. China Oncology, 2020, 30(6): 428-434.
|
[6] |
XU Yaozong , GU Xiao , WANG Fei , LUAN Yang , LU Shengming , HUANG Tianbao , DING Xuefei .
Clinical features of prostate cancer patients with Gleason score 8-10 and low preoperative PSA level
[J]. China Oncology, 2020, 30(5): 383-387.
|
[7] |
XIE Tiansong , MA Xiaoxi , TONG Tong , ZHOU Zhengrong .
Evaluating hyaluronan content of pancreatic cancer based on CT texture analysis
[J]. China Oncology, 2020, 30(3): 224-230.
|
[8] |
ZHU Xiaodong, CHEN Siyuan.
Combination therapy of immune checkpoint inhibitors: from rationale to practice
[J]. China Oncology, 2020, 30(12): 969-976.
|
[9] |
WANG Jie .
Challenges and directions of immune checkpoint inhibitors in the treatment of lung cancer
[J]. China Oncology, 2020, 30(10): 744-749.
|
[10] |
LONG Yaoxian, WANG Maomao, CAI Zhifu, ZHANG Jieqing, LI Li.
Effect of adiponectin on migration and invasion of endometrial cancer cells via AMPK/mTOR/4EBP1 pathway
[J]. China Oncology, 2020, 30(1): 25-31.
|
[11] |
GENG Wenwen, PU Qian, GAO Haidong.
The effects of Runx2 on TGF-β1-induced epithelial-mesenchymal transition in lung cancer A549 cells
[J]. China Oncology, 2019, 29(9): 681-687.
|
[12] |
SUN Ruihong,WANG Xiang,SHEN Lijuan,MENG Fanhua,YIN Huabin .
Intravoxel incoherent motion parameters of breast cancer at MRI: effect of region of interest on parameter measurement consistency
[J]. China Oncology, 2019, 29(9): 700-708.
|
[13] |
SHI Wei, YU Xiaoli.
Stereotactic body radiation therapy in spinal oligometastases of breast cancer
[J]. China Oncology, 2019, 29(9): 736-745.
|
[14] |
MA Xiaokai,HUANG Jiankang,ZHU Bo,PENG Defeng,ZHOU Rui,WANG Shengying .
Clinical characteristics of papillary thyroid microcarcinoma and risk factors for cervical lymph node metastasis: a clinical analysis of 228 cases
[J]. China Oncology, 2019, 29(8): 590-594.
|
[15] |
MIAO Changfeng,MA Yuntao,WANG Xiaopeng,HU Ming,YANG Xiaojun .
Construction of the risk factor model of gastric cancer and its value in screening opportunity and options
[J]. China Oncology, 2019, 29(7): 501-507.
|